Provident Financial Services(PFS)
搜索文档
Provident Bank Strengthens Human Resources Team with Senior Vice President to Drive the Bank's People Development Strategy
GlobeNewswire News Room· 2024-11-21 21:00
ISELIN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, is pleased to announce that Kim Strignile has joined the Human Resources team as Senior Vice President, HR Business Partner Director. Ms. Strignile will lead the bank’s HR Business Partner and Talent Acquisition teams, playing a pivotal role in driving its people strategy. In addition, Ms. Strignile will serve as a trusted advisor and change agent, collaborating closely with Provident’s leaders ...
Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update
GlobeNewswire News Room· 2024-11-12 05:05
-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) -- -- 50% relative risk reduction of progression or death with GRANITE vs. control in low ctDNA subgroup (HR=0.50 [90% CI, 0.20-1.28]) -- -- Progressing through court-administered financial restructuring process with continued interest from multiple parties EMERYVILLE, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (OTC: GRTSQ), a clinical-stage biotechnolo ...
Provident Financial Services(PFS) - 2024 Q3 - Quarterly Report
2024-11-08 05:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-31566 PROVIDENT FINANCIAL SERVICES, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 42-1547151 (State or Other Ju ...
Provident Financial Services(PFS) - 2024 Q3 - Quarterly Results
2024-10-31 01:54
Provident Financial Services, Inc. Reports Third Quarter Earnings and Declares Quarterly Cash Dividend ISELIN, NJ, October 29, 2024 - Provident Financial Services, Inc. (NYSE:PFS) (the "Company") reported net income of $46.4 million, or $0.36 per basic and diluted share for the three months ended September 30, 2024, compared to a net loss of $11.5 million, or $0.11 per basic and diluted share, for the three months ended June 30, 2024 and net income of $28.5 million, or $0.38 per basic and diluted share, for ...
Provident Financial Services(PFS) - 2024 Q3 - Earnings Call Transcript
2024-10-31 00:35
财务数据和关键指标变化 - 第三季度净收益为4640万美元,每股收益为0.36美元,年化调整后的平均资产回报率为0.95%,平均有形股本回报率为14.53% [6][13] - 调整后的税前预拨准备金回报率为1.48%,资本充足,超出被视为良好资本化的水平 [7] - 每股有形账面价值增加4.5%至13.66美元,有形普通股本比率为7.68% [7] 各条业务线数据和关键指标变化 - 第三季度商业贷款团队关闭了约4.89亿美元的新商业贷款,贷款净增长约3900万美元 [8][9] - 费基业务表现良好,Provident Protection Plus在第三季度实现了13%的有机增长 [10] - Beacon Trust管理的资产在本季度增长4%,达到42亿美元,年初至今增长10% [11] 各个市场数据和关键指标变化 - 平均存款成本增加9个基点至2.36%,存款总额增长2200万美元,主要集中在短期存款证上 [8][17] - 贷款总额在本季度基本持平,商业和工业贷款增加9400万美元,多家庭贷款增加3700万美元 [16] 公司战略和发展方向和行业竞争 - 公司完成了Lakeland Bank的核心系统转换,成功整合文化并保留了几乎所有的遗留客户,预计将继续利用协同效应提升收益 [5] - 公司对未来的经营环境持乐观态度,预计将继续实现业务增长和收入提升机会 [12] 管理层对经营环境和未来前景的评论 - 管理层指出,尽管贷款需求疲软和存款成本上升,但经济增长强劲,银行业前景乐观 [6] - 管理层对未来表现持乐观态度,预计将迎来更有利的经营环境和强劲的信贷质量 [12][39] 其他重要信息 - 第三季度非利息收入增加至2700万美元,反映了与Lakeland的合并以及财富管理和保险子公司的强劲表现 [21] - 预计2025年资产回报率约为1.15%,有形股本回报率约为16% [23] 问答环节所有提问和回答 问题: 是否考虑出售商业房地产贷款以降低集中度 - 管理层表示没有此类讨论,认为当前的贷款组合没有系统性恶化,符合风险容忍度 [24] 问题: 对证券投资组合重组的看法 - 管理层表示目前没有重组的计划,对证券投资组合的质量和表现感到满意 [25] 问题: 关于明年的利差指导,需何种美联储行动才能达到上限 - 管理层认为,利差扩张更多取决于存款的自然重定价能力,而非美联储的行动 [26][28] 问题: 费用增长的压力来源 - 管理层提到,费用增长主要是由于合并后成本节省的实现延迟,以及季节性费用和薪酬增长 [33] 问题: 对贷款需求和客户活动的看法 - 管理层表示,合并后的整合完成后,客户活动有所增加,市场情绪也在改善 [36][39] 问题: 关于存款成本下降的预期 - 管理层表示,团队在客户沟通方面做得很好,预计未来的存款贝塔将保持相似水平 [47][49] 问题: 费收入协同效应的潜力 - 管理层指出,合并后在保险和财富管理方面的商业活动显著增加,预计将继续推动收入增长 [51][54]
Provident Financial (PFS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2024-10-30 08:06
Provident Financial (PFS) reported $210.56 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 82.2%. EPS of $0.36 for the same period compares to $0.38 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $211.25 million, representing a surprise of -0.33%. The company delivered an EPS surprise of -21.74%, with the consensus EPS estimate being $0.46. While investors scrutinize revenue and earnings changes year-over-year and how they comp ...
Provident Financial (PFS) Lags Q3 Earnings and Revenue Estimates
ZACKS· 2024-10-30 07:20
Provident Financial (PFS) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.38 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -21.74%. A quarter ago, it was expected that this holding company for The Provident Bank would post earnings of $0.28 per share when it actually produced earnings of $0.06, delivering a surprise of -78.57%. Ove ...
Provident Financial Services, Inc. Reports Third Quarter Earnings and Declares Quarterly Cash Dividend
GlobeNewswire News Room· 2024-10-30 05:00
ISELIN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the "Company") reported net income of $46.4 million, or $0.36 per basic and diluted share for the three months ended September 30, 2024, compared to a net loss of $11.5 million, or $0.11 per basic and diluted share, for the three months ended June 30, 2024 and net income of $28.5 million, or $0.38 per basic and diluted share, for the three months ended September 30, 2023. For the nine months ended September 30, 20 ...
IGCS Late Breaking Abstract and The Lancet: Akeso Published Positive PFS and OS Results from Phase 3 First-Line Study of Cadonilimab in Cervical Cancer
Prnewswire· 2024-10-16 19:02
HONG KONG, Oct. 16, 2024 /PRNewswire/ -- Akeso Biopharma (9926.HK) (" Akeso", the "Company" ) announced positive results in progression-free survival (PFS) and overall survival (OS) from its Phase 3 clinical study (COMPASSION-16/AK104-303). This study evaluated the efficacy of its independently developed PD1/CTLA-4 bispecific antibody, 开坦尼® (cadonilimab), in combination with or without platinum-based chemotherapy and bevacizumab, compared to placebo with platinum-based chemotherapy and bevacizumab for first ...
Provident Bank Announces $88,000 in Grants to Nine New Jersey Non-Profit Organizations
GlobeNewswire News Room· 2024-09-16 20:00
ISELIN, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, announced today that the bank has awarded funding to nine local non-profit organizations focused on community development, economic empowerment, financial literacy and education and support for housing and homeownership in low and moderate-income communities. Since July 2023, Provident Bank has partnered with 13 local New Jersey-based non-profits via their Community Partnership Program, with th ...